Strategic Governing Group - Translational Safety

Member Login

SGGTS part of IMI 2

2014.10.10 John Doe

The projects of the SGG TS will be part of a new European program, called IMI 2, which follows the Innovative Medicines Initiative (IMI) running since 2009.
Like its forerunner program, IMI 2 will be a joint initiative of the European Commission (EC) and EFPIA with an overall budget of 3.27 billion Euros for seven years.

The budget is provided by both, the EC and the EFPIA companies.
While IMI is focusing on novel research approaches, the development of new therapies and their applications in the patient will be addressed in IMI 2 projects.

Total € 3.27 Billion:
EU contribution € 1.638 Billion
EFPIA's contribution Up to € 1.425 Billion
additional contributions Up to € 213 million